JP2025508798A5 - - Google Patents

Info

Publication number
JP2025508798A5
JP2025508798A5 JP2024549607A JP2024549607A JP2025508798A5 JP 2025508798 A5 JP2025508798 A5 JP 2025508798A5 JP 2024549607 A JP2024549607 A JP 2024549607A JP 2024549607 A JP2024549607 A JP 2024549607A JP 2025508798 A5 JP2025508798 A5 JP 2025508798A5
Authority
JP
Japan
Prior art keywords
peo
polymer
lipid
approximately
blocks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549607A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508798A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/054613 external-priority patent/WO2023161378A1/en
Publication of JP2025508798A publication Critical patent/JP2025508798A/ja
Publication of JP2025508798A5 publication Critical patent/JP2025508798A5/ja
Pending legal-status Critical Current

Links

JP2024549607A 2022-02-23 2023-02-23 脂質とブロックコポリマーとを含むポリマー-脂質ハイブリッドナノ粒子ならびにその作製方法および使用方法 Pending JP2025508798A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158324 2022-02-23
EP22158324.8 2022-02-23
PCT/EP2023/054613 WO2023161378A1 (en) 2022-02-23 2023-02-23 Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof

Publications (2)

Publication Number Publication Date
JP2025508798A JP2025508798A (ja) 2025-04-10
JP2025508798A5 true JP2025508798A5 (https=) 2026-03-02

Family

ID=80448440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549607A Pending JP2025508798A (ja) 2022-02-23 2023-02-23 脂質とブロックコポリマーとを含むポリマー-脂質ハイブリッドナノ粒子ならびにその作製方法および使用方法

Country Status (6)

Country Link
US (1) US20250235532A1 (https=)
EP (1) EP4482477A1 (https=)
JP (1) JP2025508798A (https=)
AU (1) AU2023226175A1 (https=)
CA (1) CA3244864A1 (https=)
WO (1) WO2023161378A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026062291A1 (en) 2024-09-23 2026-03-26 Aldexchem Kft. Silicon-containing spleen-targeted lnp delivery systems

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
EP4218808A3 (en) 2012-03-12 2023-08-09 Advanced BioAdjuvants, LLC Adjuvant and vaccine compositions
US9254311B2 (en) * 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
CN104936579B (zh) 2012-11-19 2020-02-07 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
EP4331620A3 (en) * 2012-12-07 2024-12-04 Translate Bio, Inc. Lipidic nanoparticles for mrna delivery
EP3160448B1 (en) * 2014-06-26 2025-08-06 Ramot at Tel-Aviv University Ltd. Liposomal formulations for delivery of nucleic acids
US9636397B2 (en) 2015-03-24 2017-05-02 VaxLiant, LLC Adjuvant compositions and related methods
WO2021236855A1 (en) * 2020-05-19 2021-11-25 Orna Therapeutics, Inc. Circular rna compositions and methods

Similar Documents

Publication Publication Date Title
Zhang et al. DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine
Rinoldi et al. Nanotechnology‐assisted RNA delivery: from nucleic acid therapeutics to COVID‐19 vaccines
Tan et al. Optimization of an mRNA vaccine assisted with cyclodextrin-polyethyleneimine conjugates
EP3573656B1 (en) Core/shell structure platform for immunotherapy
Ruan et al. Advanced biomaterials for cell‐specific modulation and restore of cancer immunotherapy
JP6782415B2 (ja) 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法
CN114746401A (zh) 用于核酸递送的可离子化脂质
JP6016970B2 (ja) インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
CN116685331A (zh) 用融合相关的小跨膜蛋白配制的蛋白脂质囊泡
KR102948789B1 (ko) 항원 제시 세포를 표적으로 하는 지질 조성물 및 이의 용도
Huang et al. Recent advances in delivery systems for genetic and other novel vaccines
Gu et al. Building a better silver bullet: current status and perspectives of non‐viral vectors for mRNA vaccines
CN119654141A (zh) 脂质纳米颗粒的组合物
JP2025508798A5 (https=)
WO2025113407A1 (zh) 高效递送疫苗的脂质体载体及脂质体疫苗的制备与用途
CN110448695A (zh) 一种mRNA疫苗递送载体及其制备方法
CN119930462B (zh) 基于RLRs受体激动剂的疫苗佐剂脂质化合物、包含其的组合物及用途
US20260102477A1 (en) Tumor-Associated Antigen Based Cancer Vaccine
Liu et al. Antigen-encoding circular single-stranded DNA for cancer vaccine
Dodopoulos et al. Delivering mRNA Vaccines: Emerging Strategies and Clinical Potential of Nanocarrier Systems For Cancer Treatment
Yasar Non-invasive vaccination by nanoparticle-based messenger RNA (mRNA) delivery via the transfollicular route
WO2024216243A2 (en) Peptide-based vaccines and methods for treatment
WO2025212851A2 (en) mRNA COMPOSITIONS AND USES THEREOF IN VARICELLA ZOSTER VIRUS VACCINES
HK40076004A (en) Core/shell structure platform for immunotherapy
HK40106866B (zh) 靶向抗原呈递细胞的脂质组合物及其应用